Drug-eluting stents: a mechanical and pharmacologic approach to coronary artery disease.

Item

http://www.wikidata.org/entity/Q35945466

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Drug-eluting stents: a mechanical and pharmacologic approach to coronary artery disease.

@ast

Drug-eluting stents: a mechanical and pharmacologic approach to coronary artery disease.

@en

type

Item

label

Drug-eluting stents: a mechanical and pharmacologic approach to coronary artery disease.

@ast

Drug-eluting stents: a mechanical and pharmacologic approach to coronary artery disease.

@en

prefLabel

Drug-eluting stents: a mechanical and pharmacologic approach to coronary artery disease.

@ast

Drug-eluting stents: a mechanical and pharmacologic approach to coronary artery disease.

@en

P1476

Drug-eluting stents: a mechanical and pharmacologic approach to coronary artery disease.

@en

P2093

Alexander J Ansara

http://www.w3.org/2001/XMLSchema#string

Jason M Enders

http://www.w3.org/2001/XMLSchema#string

Paul P Dobesh

http://www.w3.org/2001/XMLSchema#string

Zachary A Stacy

http://www.w3.org/2001/XMLSchema#string

P2860

Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial

Local delivery of enoxaparin to decrease restenosis after stenting: results of initial multicenter trial: Polish-American Local Lovenox NIR Assessment study (The POLONIA study)

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban

Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions

Long-term efficacy of platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention

Oral everolimus inhibits in-stent neointimal growth

A paclitaxel-eluting stent for the prevention of coronary restenosis

TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery

P304

1554-1577

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1592/PHCO.24.16.1554.50955

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51368791

http://www.w3.org/2001/XMLSchema#string

P698

15537561

http://www.w3.org/2001/XMLSchema#string